TCI Fund Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,517,639
Closed -$882M 11
2024
Q1
$882M Sell
1,517,639
-1,628,743
-52% -$914M 2.22% 9
2023
Q4
$1.67B Sell
3,146,382
-46,800
-1% -$22.7M 4.64% 9
2023
Q3
$1.62B Buy
3,193,182
+20,000
+0.6% +$10.7M 5.86% 8
2023
Q2
$1.66B Buy
3,173,182
+2,339,032
+280% +$1.26B 4.92% 9
2023
Q1
$481M Buy
834,150
+770,380
+1,208% +$434M 1.65% 9
2022
Q4
$35.1M Buy
+63,770
New +$33.8M 0.12% 9

Other funds holding TMO

TCI Fund Management's TMO Position: Q2 2024 in Review

TCI Fund Management sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 1,517,639 shares — an estimated $882M sold.

TCI Fund Management first reported a position in TMO in Q4 2022 and held it in 6 quarters. The position peaked at $1.67B in Q4 2023. 2,543 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • TCI Fund Management reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • TCI Fund Management sold 1,517,639 Thermo Fisher Scientific shares in Q2 2024, an estimated $882M.
  • TCI Fund Management first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 6 quarters.
  • TCI Fund Management's Thermo Fisher Scientific position peaked at $1.67B in Q4 2023.
  • 2,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on TCI Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.